Helicobacter pylori strain 22389

Helicobacter pylori strain 22389 is a microaerophilic, Gram-negative bacterium characterized by its spirilla shape and single-cell arrangement. It possesses flagella, which contribute to its mobility, although it is noted that it does not exhibit active movement. This strain is mesophilic with an optimal growth temperature of 37°C. H. pylori strain 22389 is primarily host-associated, with a diverse range of hosts that includes Homo sapiens (humans), Gallus gallus (chickens), various Aves (birds), Primates, Mammalia, Rodentia, Cricetinae (hamsters), and even amoebas. This bacterium has a free-living biotic relationship, indicating its capacity to survive outside of its hosts. The health effects linked to H. pylori strain 22389 are significant and multifaceted. It is associated with chronic gastric conditions such as gastritis and peptic ulcer disease, as well as more severe outcomes like gastric cancer, including adenocarcinoma and mucosa-associated lymphoid tissue lymphoma. The strain has been implicated in a range of gastrointestinal diseases and can lead to asymptomatic mucosal inflammatory responses, chronic gastritis, and conditions such as dyspepsia and hypochlorhydria. Given its pathogenicity specifically in humans and its extensive association with various gastrointestinal disorders, H. pylori strain 22389 serves as a crucial focus in understanding gastric health and disease. Its ability to thrive in the human stomach and its broad host range highlight its ecological adaptability and potential impact on public health. The strain's role in chronic inflammation and cancer development underscores the importance of ongoing research into its mechanisms and interactions within the host environment.